Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
How does research into cancer prevention, screening, and diagnosis help people living with cancer? Carolyn Aldigé, President and Founder of the Prevent Cancer Foundation, describes the sessions that made the biggest impact on her from the 2015 GI Cancers Symposium.
Dr. Neal Meropol and his colleagues created the video-based PRE-ACT program to answer questions and concerns patients have about participating in clinical trials. This tool is now available on Cancer.Net.
Recognizing the dramatic advances in the treatment of chronic lymphocytic leukemia (CLL), ASCO named the approval of four new drugs for this disease in 2014 as its first “Advance of the Year.”
Research presented this weekend will highlight three potential new approaches to the treatment of colorectal cancer.
In these two podcasts, Dr. Sundar Jagannath and Dr. Hope Rugo share the latest highlights in myeloma and breast cancer research.
In this podcast, Jeffrey S. Weber, MD, PhD, explains the recent ASCO statement on phase I clinical trials and why these studies are important treatment options to discuss with your doctor.
According to a new Journal of Clinical Oncology study, physical inactivity and TV watching are linked to higher mortality risks for colorectal cancer survivors. However, you don't have to miss your favorite shows to become more active.
In this podcast, Dr. Howard Sandler explains the recent ASCO guideline endorsement about radiation therapy after prostate surgery.
The cost of cancer care is often a major source of stress for people with cancer. For some, these costs force them to make major lifestyle and medical care changes. Studies presented at both ASCO’s Palliative Care in Oncology and Quality Care Symposia shed more light on the financial challenges of cancer.